Clinical Bridging Study Between V181 (Dengue Quadrivalent Vaccine rDENVΔ30 [Live, Attenuated]) to Butantan Dengue Vaccine (Butantan - DV) in Healthy Adults 18 to 50 Years of Age in Brazil (V181 - 002)

NCT05710224 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1364

Enrollment

OTHER_GOV

Sponsor class

Conditions

Dengue

Interventions

BIOLOGICAL: V181
BIOLOGICAL: Butantan - DV

Sponsor

Butantan Institute

Collaborators

[object Object]